JP2018046826A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018046826A5 JP2018046826A5 JP2017195118A JP2017195118A JP2018046826A5 JP 2018046826 A5 JP2018046826 A5 JP 2018046826A5 JP 2017195118 A JP2017195118 A JP 2017195118A JP 2017195118 A JP2017195118 A JP 2017195118A JP 2018046826 A5 JP2018046826 A5 JP 2018046826A5
- Authority
- JP
- Japan
- Prior art keywords
- alzheimer
- disease
- expression level
- subject
- matrigel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161543416P | 2011-10-05 | 2011-10-05 | |
| US61/543,416 | 2011-10-05 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014534811A Division JP2014528247A (ja) | 2011-10-05 | 2012-10-05 | 神経変性状態の刺激誘発性ゲノムプロファイルマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018046826A JP2018046826A (ja) | 2018-03-29 |
| JP2018046826A5 true JP2018046826A5 (enExample) | 2018-07-26 |
| JP6636488B2 JP6636488B2 (ja) | 2020-01-29 |
Family
ID=47116384
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014534811A Pending JP2014528247A (ja) | 2011-10-05 | 2012-10-05 | 神経変性状態の刺激誘発性ゲノムプロファイルマーカー |
| JP2017195118A Active JP6636488B2 (ja) | 2011-10-05 | 2017-10-05 | 神経変性状態の刺激誘発性ゲノムプロファイルマーカー |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014534811A Pending JP2014528247A (ja) | 2011-10-05 | 2012-10-05 | 神経変性状態の刺激誘発性ゲノムプロファイルマーカー |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20140235496A1 (enExample) |
| EP (1) | EP2764120B1 (enExample) |
| JP (2) | JP2014528247A (enExample) |
| CA (1) | CA2861668C (enExample) |
| WO (1) | WO2013052922A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015103495A1 (en) * | 2014-01-03 | 2015-07-09 | Blanchette Rockefeller Neurosciences Institute | Convergence of aggregation rate with validated peripheral diagnostics for alzheimer's disease |
| CN105353135A (zh) * | 2015-11-23 | 2016-02-24 | 中国人民解放军第三军医大学第一附属医院 | 阿尔茨海默病标志物的用途 |
| WO2017117333A1 (en) * | 2015-12-30 | 2017-07-06 | Cellular Dynamics International, Inc. | Microtissue formation using stem cell-derived human hepatocytes |
| WO2018183703A1 (en) | 2017-03-31 | 2018-10-04 | NeuroDiagnostics LLC | Lymphocyte-based morphometric test for alzheimer's disease |
| US20210033628A1 (en) * | 2018-04-30 | 2021-02-04 | Cedars-Sinai Medical Center | Diagnostic and drug screening for molecular signatures of early onset sporadic parkinson's disease |
| WO2022132856A1 (en) * | 2020-12-16 | 2022-06-23 | Synaptogenix, Inc. | Treatment of amyotrophic lateral sclerosis using pkc activators |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976816A (en) | 1993-05-03 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Cell tests for alzheimer's disease |
| US6300085B1 (en) | 1993-05-03 | 2001-10-09 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic method for Alzheimer's disease |
| AU719038B2 (en) * | 1996-03-29 | 2000-05-04 | Trustees Of Boston University | Methods for diagnosing and treating Alzheimer's disease |
| US6218122B1 (en) | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
| EP1934618B1 (en) | 2005-10-11 | 2009-05-13 | Blanchette Rockefeller Neurosciences Institute | Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (adsmb) |
| US20080058396A1 (en) | 2006-07-28 | 2008-03-06 | Alkon Daniel L | Methods of stimulating cellular growth, synaptic remodelling and consolidation of long-term memory |
| WO2008077094A2 (en) * | 2006-12-19 | 2008-06-26 | Children's Medical Center Corporation | Methods for promoting neovascularization |
| EP3586839A1 (en) | 2008-07-28 | 2020-01-01 | Blanchette Rockefeller Neurosciences, Institute | Pkc-activating compounds for the treatment of neurodegenerative diseases |
| JP2011529344A (ja) * | 2008-07-28 | 2011-12-08 | ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート | アルツハイマー病の刺激誘発ゲノムプロフィールマーカー |
| KR101054725B1 (ko) * | 2008-07-31 | 2011-08-05 | 재단법인서울대학교산학협력재단 | 세포외기질 성분을 함유하는 노화조절용 조성물 및 이를이용한 노화세포의 노화조절방법 |
| EP2483684B1 (en) * | 2009-10-02 | 2018-04-18 | Blanchette Rockefeller Neurosciences, Institute | Fibroblast growth patterns to diagnose alzheimer's disease |
-
2012
- 2012-10-05 US US14/346,822 patent/US20140235496A1/en active Pending
- 2012-10-05 CA CA2861668A patent/CA2861668C/en active Active
- 2012-10-05 WO PCT/US2012/059137 patent/WO2013052922A1/en not_active Ceased
- 2012-10-05 JP JP2014534811A patent/JP2014528247A/ja active Pending
- 2012-10-05 EP EP12780586.9A patent/EP2764120B1/en active Active
-
2017
- 2017-10-05 JP JP2017195118A patent/JP6636488B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025069171A (ja) | 急性呼吸器感染症を診断および処置するための方法 | |
| Miyake et al. | Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters | |
| Angebault et al. | Combined bacterial and fungal intestinal microbiota analyses: Impact of storage conditions and DNA extraction protocols | |
| JP2015154774A5 (enExample) | ||
| WO2009149026A3 (en) | Genomic approaches to fetal treatment and diagnosis | |
| BRPI0607753A2 (pt) | método para prever um efeito clìnico em resposta a um tratamento de uma leucemia; método para prever um efeito clìnico de uma leucemia; método para selecionar um tratamento para um paciente com leucemia; método para o diagnóstico ou monitoramento de ocorrência, desenvolvimento, progressão ou tratamento de uma leucemia; arranjo para uso num método para prever um efeito clìnico para um paciente aml; arranjo para uso num método de diagnóstico de aml; meio legìvel por computador; kit para o prognóstico de aml | |
| WO2007011412A3 (en) | Diagnosis and prognosis of infectious diesease clinical phenotypes and other physiologic states using host gene expresion biomarkers in blood | |
| CN108348166B (zh) | 用于与抗生素使用相关的感染性疾病及其它健康状况的源自微生物群系的诊断及治疗方法和系统 | |
| CN108350510A (zh) | 用于胃肠健康相关病症的源自微生物群系的诊断及治疗方法和系统 | |
| JP2019520042A5 (enExample) | ||
| Bouquet et al. | Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing | |
| JP2019528081A5 (enExample) | ||
| CA2791464A1 (en) | Method of diagnosis of obesity | |
| WO2012080754A3 (en) | Oligonucleotide probe set and methods of microbiota profiling | |
| JP2019510473A5 (enExample) | ||
| US20230017064A1 (en) | Methods for the characterization of fluid | |
| JP2013503617A5 (enExample) | ||
| JP6485843B2 (ja) | 関節リウマチのバイオマーカー及びその使用 | |
| JP2018504909A5 (enExample) | ||
| WO2005118403A3 (en) | Methods for detecting gene expression in peripheral blood cells and uses thereof | |
| Rowley | Can a systems biology approach unlock the mysteries of Kawasaki disease? | |
| Sofia de Olazarra et al. | Rapid, Point-of-Care Host-Based Gene Expression Diagnostics Using Giant Magnetoresistive Biosensors | |
| JP2020178555A5 (enExample) | ||
| JP2020178586A5 (enExample) | ||
| JP2020174639A5 (enExample) |